Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Aridis Pharmaceuticals In...

    OTC: ARDS · Real-Time Price · USD
    0.00
    -0.00 (-100.00%)
    At close: Apr 01, 2025, 9:51 AM

    Aridis Pharmaceuticals Statistics

    Share Statistics

    Aridis Pharmaceuticals has 44.57M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 44.57M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 0%

    Shares Floating

    n/a
    		 36.9M

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 2M, so undefined% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2M

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 5.37%

    Short Ratio (days to cover)

    n/a
    		 0.22

    Valuation Ratios

    The PE ratio is -0.72 and the forward PE ratio is null. Aridis Pharmaceuticals's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.72

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 -0.91

    P/FCF Ratio

    n/a
    		 -0.76

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Aridis Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.32, with a Debt / Equity ratio of -0.25.

    Current Ratio

    n/a
    		 0.32

    Quick Ratio

    n/a
    		 0.32

    Debt / Equity

    n/a
    		 -0.25

    Debt / EBITDA

    n/a
    		 -0.21

    Debt / FCF

    n/a
    		 -0.21

    Interest Coverage

    n/a
    		 -79.35

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-831,054.05

    Employee Count

    n/a
    		 37

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 378K

    Effective Tax Rate

    n/a
    		 -1.24%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is -26.04, so Aridis Pharmaceuticals's price volatility has been lower than the market average.

    Beta

    n/a
    		 -26.04

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 0

    200-Day Moving Average

    n/a
    		 0.01

    Relative Strength Index (RSI)

    n/a
    		 50.3

    Average Volume (20 Days)

    n/a
    		 n/a

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -29.99M

    Net Income

    n/a
    		 -30.75M

    EBITDA

    n/a
    		 -29.51M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -1.64
    Full Income Statement

    Balance Sheet

    The company has 4.88M in cash and 6.13M in debt, giving a net cash position of -1.25M.

    Cash & Cash Equivalents

    n/a
    		 4.88M

    Total Debt

    n/a
    		 6.13M

    Net Cash

    n/a
    		 -1.25M

    Retained Earnings

    n/a
    		 -195.67M

    Total Assets

    n/a
    		 6.53M

    Working Capital

    n/a
    		 -13.37M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -29.13M and capital expenditures -82K, giving a free cash flow of -29.21M.

    Operating Cash Flow

    n/a
    		 -29.13M

    Capital Expenditures

    n/a
    		 -82K

    Free Cash Flow

    n/a
    		 -29.21M

    FCF Per Share

    n/a
    		 -1.56
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ARDS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ARDS.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -40.63

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist